TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The Philadelphia Eagles said quarterback Jalen Hurts was diagnosed with deep vein thrombosis and blood clots in both lungs after an earlier diagnosis of a superficial clot in his left calf. He is taking blood thinners and cannot take part in contact activities; the team said it expects a full recovery, but has not announced a return date.
The Philadelphia Eagles said quarterback Jalen Hurts has deep vein thrombosis (DVT) and blood clots in both lungs, following an earlier diagnosis of a superficial clot in his left calf. Hurts is taking blood thinners and cannot participate in contact activities, the team said, putting his availability for football on hold while he receives treatment.
Hurts, 28, was initially diagnosed with a superficial vein thrombosis in his left calf after he said he was “cleated” during a game against the Los Angeles Rams in early October. According to MedPage Today’s October 20 report, a follow-up ultrasound after an October 11 game found that the clot had moved. Further testing identified DVT and clots in both lungs.
The Eagles said in an Instagram post that Hurts is receiving anticoagulant medication, commonly called blood thinners, and must avoid contact activities. The team described his outlook as positive, saying, “Jalen’s prognosis is very good, and we expect a full recovery.” It also said it anticipates no long-term effects. Those statements reflect the team’s assessment; the report did not give a treatment end date or a schedule for Hurts to return to football.
Gita Lisker, a pulmonologist at Northwell’s Long Island Jewish Medical Center, told MedPage Today that an injury can set off inflammation that raises clotting risk, while genetics may also contribute. She said it is not established whether Hurts’s injury caused the clots or whether they were already present. The report also said that an earlier superficial clot may have extended into a deep vein, or that superficial and deep clots may have existed at the same time.
Why Contact Play Is Paused
DVT forms in deeper veins, often in the legs, and a clot can travel to the lungs, where it may cause a pulmonary embolism. Hurts has been reported to have clots in both lungs, but the source does not provide details about his symptoms, the extent of the clots, or how they are affecting him. The diagnosis is serious enough to require medication and restrictions, while the team has publicly expressed confidence in his recovery.
Blood thinners reduce the risk of new clots and help stabilize existing ones as the body gradually reabsorbs them. They also increase bleeding risk. MedPage Today cited experts who said high-impact sports such as football pose particular concerns during anticoagulant treatment because tackles, cuts from cleats, and head injuries can cause bleeding. That is the reason given for keeping Hurts out of contact activities; it does not establish how long he will be sidelined.
The report says anticoagulation commonly lasts three to six months after an acute clotting event, depending on a patient’s risk factors. That is general medical context, not a confirmed treatment plan for Hurts. His actual course and return-to-play decision depend on his clinicians and the team’s assessment.
Products Worth Considering
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
Levoit Vital 100S-P Air Purifier
BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)
As an affiliate, we earn on qualifying purchases.
From Calf Clot to Lung Findings
The reported sequence began with a superficial vein clot, which forms in veins close to the skin, after Hurts said he was struck by a cleat. A later ultrasound and additional testing led to the DVT and lung-clot diagnoses. The sequence alone does not prove that the initial clot moved into a deeper vein or traveled to the lungs.
Lisker told MedPage Today that superficial thrombosis and DVT may develop together, or a superficial clot may extend into a deep vein. She said injury-related inflammation and genetic factors can be relevant. The report does not identify a confirmed cause in Hurts’s case, nor does it say whether clinicians found an underlying risk factor.
MedPage Today’s report also distinguishes typical symptoms: DVT may cause pain, swelling, or redness in one leg, while pulmonary embolism can involve shortness of breath, chest pain, palpitations, lightheadedness, or dizziness. These are general descriptions from the medical source, not a report of symptoms Hurts experienced.
““Jalen’s prognosis is very good, and we expect a full recovery.””
— Philadelphia Eagles, in an Instagram post
Cause and Return Date Unsettled
The public information does not establish whether the injury caused Hurts’s clots, whether the initial superficial clot progressed, or whether several clots were present at once. The Eagles’ statement, as summarized by MedPage Today, does not disclose the severity or precise location of the lung clots, Hurts’s symptoms, his individual treatment plan, or how long he must avoid contact.
There is also no confirmed return-to-play date in the report. The general three-to-six-month treatment range cited by Lisker should not be treated as a timetable for Hurts: duration depends on individual risk factors, and the source does not say how his doctors are applying that guidance.
Medical Review Before Return
Hurts is expected to continue anticoagulant treatment and avoid contact activities while his condition is managed. The next meaningful updates would be information from the Eagles or Hurts’s medical team about his progress, treatment duration, and when contact could be considered. The report does not identify a date for those updates or say when he might resume football.
Any decision to return would need to account for both the clotting condition and the bleeding risk associated with blood thinners. Until the team provides more information, his prognosis is described positively by the Eagles, but his playing timeline remains unknown.
Key Questions
What blood clots were reported in Jalen Hurts’s case?
The Eagles said Hurts was diagnosed with deep vein thrombosis and clots in both lungs, after an earlier diagnosis of a superficial clot in his left calf.
Is Hurts playing while taking blood thinners?
The team said Hurts cannot take part in contact activities while being treated. The report does not give a return date or say when he could resume football.
Do doctors know what caused the clots?
No cause has been confirmed in the source report. A pulmonologist said injury-related inflammation may raise clot risk, but the clots could have followed the injury or may have been present at the same time.
How long does blood-thinner treatment usually last?
The MedPage Today report says anticoagulation commonly lasts three to six months after an acute clotting event, depending on risk factors. That is general guidance and not a confirmed timeline for Hurts.
What has the Eagles said about his recovery?
The team said Hurts’s prognosis is very good, that it expects a full recovery, and that it anticipates no long-term effects. The report does not include an independent medical prognosis or a timetable for his return.
Source: rss
